Menu

Cerevel Therapeutics Holdings, Inc. CERE

Full chart Compare
Set alert

Price alert · CERE

All alert types
44.96 +44.96

Day range unavailable

52-week range unavailable

Latest period ending Dec 31, 2023 · select a line to chart its full history

Annual income statement

CERE annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
447.26M367.85M220.10M149.12M83.46M
334.64M280.26M161.85M103.30M50.29M
112.62M87.59M58.24M45.81M33.17M
-447.26M-367.85M-220.10M-149.12M-83.46M
10.57M3.92M0-224.00K0
503.00K160.00K0-24.00K45.00K
-432.84M-351.51M-225.33M-152.14M-128.39M
-432.84M-351.51M-225.33M-148.27M-128.39M
-432.84M-351.51M-225.33M-148.27M-128.39M
-432.84M-351.51M-225.33M-152.14M-128.39M
-2.67-2.32-1.65-2.01-2.90
-2.67-2.32-1.65-2.01-2.90
-2.67-2.32-1.65-2.01-2.90
-421.77M-347.43M-225.33M-152.39M-128.34M
-421.77M-347.43M-225.33M-152.39M-128.34M
162.06M151.27M136.58M73.64M44.21M
162.06M151.27M136.58M73.64M44.21M